Enhancements to protocol, informed by recent ALRN-6924 data, are designed to improve the opportunity to demonstrate protection against chemotherapy-induced severe neutropenia, alopecia (hair loss) and ...

Aileron Therapeutics’ unraveling has entered its endgame. An early look at phase 1b data persuaded the biotech to call it quits on development of its sole drug candidate—and lay off most of its ...

Advancium will evaluate ALRN-6924 as a potential therapy for retinoblastoma, a rare but devastating pediatric cancer of the eye During the option period, Advancium intends to evaluate ALRN-6924 as a ...

As early as May 18, 2021, STAT Trials Pulse by AppliedXL began to surface irregularities in the progression of Aileron Therapeutic’s ALRN-6924 trial for chemoprotection in lung cancer, signaling a ...

WHY WE’RE HERE “How hard could it be to open a sprinkler business and run our own company? I guess we found out it’s very hard.” -Renee Hoderlein, Owner of Maximum Fire Protection and Aileron ...

Aileron Therapeutics ( (ALRN)) has released its Q3 earnings. Here is a breakdown of the information Aileron Therapeutics presented to its investors. Aileron Therapeutics, Inc. is a clinical-stage ...

(RTTNews) - Aileron Therapeutics, Inc.(ALRN) a Boston-based biopharmaceutical company Friday has announced that it has rebranded itself into Rein Therapeutics, Inc. The updated name, logo, website, ...

CHICAGO--(BUSINESS WIRE)--Aileron Communications, a strategic communications agency specializing in community relations and public affairs engagement, announced today the promotions of Peter Gray to ...

The GameSir X4 Aileron Bluetooth Mobile Game Controller has been specifically designed to help improve the gaming experience for Android users, providing them with a level of control and precision ...